Apollo Therapeutics
PrivateLast Round
Series C
Jan 2, 2024
Est. Valuation
$246.75M
Total Funding Raised
$722M
Company Overview
Apollo Therapeutics is a biopharmaceutical company that translates fundamental medical research into innovative medicines by developing a diverse portfolio of pre-clinical and clinical-stage assets in oncology, inflammatory disorders, and rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Apollo Therapeutics Comparables
Compare Apollo Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Orange Grove Bio | 77% | |
| Eli Lilly and Company | 77% | |
| PureTech Health | 70% | |
Apollo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 2, 2024 | ||||
| Series C Extension | Dec 1, 2023 | ||||
| Series C | Sep 6, 2023 | ||||
| Series B | Jun 17, 2021 | ||||
| Seed | Jan 25, 2016 |
Apollo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IP Group | Series B |
| Patient Square Capital | Series C Extension, Series C, Series B |
| Reimagined Ventures | Series B |
| Imperial College London | Seed |
| M&G Investments | Series C |
| Imperial Innovations | Seed |
| University College London | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 5, 2025
Developing a monoclonal antibody treatment for pulmonary arterial hypertension (PAH).
- May 5, 2025
Collaborating with Imperial College London on new antibody treatment.
Apollo Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Apollo Therapeutics's valuation, stock price, and market status.